Moderna Inc. (MRNA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Moderna Inc.

    NASDAQ: MRNA · Real-Time Price · USD
    24.49
    -0.12 (-0.49%)
    At close: Sep 26, 2025, 3:59 PM
    24.49
    0.00%
    After-hours: Sep 26, 2025, 07:53 PM EDT

    Moderna Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 3.2B 6.85B 18.88B 17.74B
    Cost of Revenue
    		 1.46B 4.69B 5.42B 2.62B
    Gross Profit
    		 1.74B 2.15B 13.46B 15.12B
    Operating Income
    		 -3.94B -4.24B 9.42B 13.3B
    Interest Income
    		 425M 421M 200M 18M
    Pretax Income
    		 -3.61B -3.94B 9.57B 13.29B
    Net Income
    		 -3.56B -4.71B 8.36B 12.2B
    Selling & General & Admin
    		 1.17B 1.55B 1.13B 567M
    Research & Development
    		 4.54B 4.84B 3.29B 1.99B
    Other Expenses
    		 -37M n/a -388M -735M
    Operating Expenses
    		 5.68B 6.39B 4.04B 1.82B
    Interest Expense
    		 24M 38M 29M 18M
    Selling & Marketing Expenses
    		 146M 204M 121M n/a
    Cost & Expenses
    		 7.14B 11.09B 9.46B 4.44B
    Income Tax Expense
    		 -46M 772M 1.21B 1.08B
    Shares Outstanding (Basic)
    		 384M 382M 394M 403M
    Shares Outstanding (Diluted)
    		 384M 382M 416M 431M
    EPS (Basic)
    		 -9.27 -12.34 21.26 30.31
    EPS (Diluted)
    		 -9.27 -12.34 20.10 28.29
    EBITDA
    		 -3.39B -3.28B 9.77B 13.53B
    EBIT
    		 -3.58B -3.9B 9.42B 13.3B
    Depreciation & Amortization
    		 189M 621M 348M 232M

    Add to Watchlist